ProCE Banner Activity

CE / CME

Strengthening the Safety Net With Advanced Nursing Strategies for Managing Immunotherapy-Related Adverse Events

Video

In this certified on-demand webcast, expert faculty address how to identify and manage immunotherapy-related adverse events following treatment with immune checkpoint inhibitor combinations and overcome barriers to improve patient outcomes.

Nurse Practitioners/Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: April 21, 2025

Expiration: October 20, 2025

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC (CCO) and Practicing Clinicians Exchange (PCE)

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Merck Sharp & Dohme LLC.

Bristol Myers Squibb

Merck Sharp & Dohme, LLC

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange, LLC

ProCE Banner

Target Audience

This activity is intended for NPs, PAs, and other healthcare professionals who care for patients with cancer.

Program Learning Goal

This activity is intended to enhance learners' knowledge, confidence, and clinical expertise in proactively managing immune-related adverse events in cancer patients undergoing immunotherapy, ultimately driving improved patient care, safety, and treatment outcomes.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Develop a proactive nursing care plan for early identification and effective management of immune-related adverse events (irAEs) from ICI and ICI-targeted therapy combinations, focusing on maintaining quality of life, treatment adherence, and interdisciplinary collaboration

  • Differentiate between immune-related and targeted therapy-associated adverse events to guide appropriate nursing interventions and patient care strategies

  • Apply current guidelines for adjusting or withholding immunotherapy in response to adverse events, ensuring safe and effective patient care during ICI combination treatments

  • Educate patients on recognizing and promptly reporting signs and symptoms of irAEs, providing them with resources to support informed self-management

Disclosure

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships. 

Primary Author

Suzanne McGettigan, MSN, CRNP, AOCN, ANP-BC: consultant/advisor/speaker: Bristol Myers Squibb, Pfizer, Regeneron.

Denise Rouse, MS, PA-C: consultant/advisor/speaker: Bristol Myers Squibb, Catalyst, Johnson & Johnson, Puma Biotechnology.

Beth Sandy, MSN, CRNP, FAPO: consultant/advisor/speaker: Amgen, AstraZeneca, Jazz, Lilly, Merck, Pfizer, Takeda.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 21, 2025, through October 20, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour, including 1 hour of pharmacotherapy credit. 

Physician Associate Continuing Medical Education

AAPA CME Accreditation - AAPA

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until October 20, 2025. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.